Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
Humana Medical Policy Updates – July 2022
Click here to view the Humana Medical Policy Updates Updates »
July 2022 Humana Medical Policy Updates;
- Accrufer™ (ferric maltol)
- ADHD Long Acting Stimulants
- Adlarity® (donepezil) transdermal patch
- Aduhelm (aducanumab-avwa)
- Aduhelm™ (aducanumab-avwa)
- Afinitor/Afinitor Disperz (everolimus)
- AHCA Continuity of Care
- Aklief® (trifarotene)
- Akynzeo (fosnetupitant/netupitant-palonosetron)
- Alecensa (alectinib)
- Allergy Ophthalmics
- Allergy Ophthalmics
- Aloxi (palonosetron)
- Alpha-1 Proteinase Inhibitors (Aralast NP®, Glassia®)
- Alpha-1 Proteinase Inhibitors (Prolastin-C®, Zemaira®)
- Alphagan® P (brimonidine)
- Amondys 45 (casimersen)
- Amzeeq® (minocycline) topical foam
- Angiotensin Blocking & Renin Inhibitor Agents
- Angiotensin Blocking Agents
- Antidepressant Agents
- Atgam® (antithymocyte immune globulin, equine)
- Aubagio® (teriflunomide)
- Avsola® (infliximab-axxq)
- Azopt® (brinzolamide ophthalmic suspension) 1%
- Baclofen Products (Fleqsuvy™, generic baclofen oral solution, Ozobax™, Lyvispah™)
- Bafiertam™ (monomethyl fumarate)
- Banzel® (rufinamide)
- Benlysta® (belimumab)
- Benzodiazepine Limited Days’ Supply
- Beovu® (brolucizumab)
- Beovu® (brolucizumab)
- Beovu® (brolucizumab)
- Betaseron® (interferon beta-1b)
- Bevacizumab products
- Biguanide Agents
- Blincyto® (blinatumomab)
- Bortezomib products (Velcade and Bortezomib for injection)
- Bosulif® (bosutinib)
- Bosulif® (bosutinib)
- Bowel Prep Agents
- Bowel Prep Agents
- Calcitonin gene-related peptide (CGRP) inhibitors
- Calcitonin gene-related peptide (CGRP) inhibitors
- Chiropractic Care
- Cimzia® (certolizumab pegol)
- Cimzia® (certolizumab pegol)
- Code Compendium (Laboratory)
- Cosopt® (dorzolamide and timolol ophthalmic solution)
- Cotellic® (cobimetinib)
- Cotellic® (cobimetinib)
- Cyramza™ (ramucirumab)
- Dayvigo™ (lemborexant)
- Desmopressin Nasal Spray
- Dojolvi™ (triheptanoin) Oral Liquid
- Doxycycline Antibiotics
- Dupixent® (dupilumab) injection
- Dupixent® (dupilumab) injection
- Electrical Stimulators – Diaphragmatic/Phrenic Nerve, Functional and Neuromuscular
- EMSAM® (selegiline transdermal system)
- Enjaymo™ (sutimlimab-jome)
- Envarsus XR® (tacrolimus extended-release)
- Envarsus XR® (tacrolimus extended-release)
- Esbriet® (pirfenidone)
- Fecal Microbiota Transplantation
- Foot Bath Medications
- Fusion Imaging
- Fusion Imaging
- Galafold®(migalastat)
- Gattex® (teduglutide)
- Genetic and Biomarker Testing for Alzheimer Disease
- Genetic Testing for Muscular Dystrophy and Spinal Muscular Atrophy
- Gilenya® (fingolimod)
- Ibsrela® (tenapanor)
- Inbrija ® (levodopa) capsule for inhalation
- Inbrija® (levodopa) capsule for inhalation
- Increlex® (mecasermin injection)
- Ingrezza® (valbenazine)
- Injections for Chronic Pain Conditions
- Inlyta (axitinib)
- Intensity Modulated Radiation Therapy
- Intraocular Lens Implants
- Isturisa® (osilodrostat)
- Janus Kinase 2 (JAK2) V617F, Exon 12 -15, Calreticulin (CALR) and MPL Mutation Analysis
- Kineret® (anakinra)
- Kisqali® (ribociclib)
- Korsuva™ (difelikefalin)
- Kymriah™ (tisagenlecleucel)
- Kymriah™ (tisagenlecleucel)
- Laboratory Analysis for Prostate Cancer
- Laparoscopic Hiatal Hernia Repair
- Manipulation Under Anesthesia
- Mekinist® (trametinib)
- Mekinist® (trametinib)
- Molecular Testing for HLA B27 for Ankylosing Spondylitis
- Muscle Relaxants
- Nerlynx (neratinib)
- Nexavar (sorafenib)
- Non-Benzodiazepine Hypnotics
- Noninvasive Prenatal Screening
- Non-preferred Pegfilgrastim Products – Nyvepria (pegfilgrastim-apfg) and Ziextenzo (pegfilgrastim-bmez)
- Nuedexta® (dextromethorphan and quinidine)
- Nurtec™ ODT (rimegepant)
- Obesity Medications
- Obstructive Sleep Apnea and Other Sleep Related Breathing Disorders Nonsurgical Treatments
- Obstructive Sleep Apnea and Other Sleep Related Breathing Disorders Surgical Treatments
- Olumiant® (baricitinib)
- Olumiant® (baricitinib)
- Olumiant® (baricitinib)
- Opdivo® (nivolumab)
- Ophthalmic Beta Blockers
- Ophthalmic Beta Blockers
- Orilissa™ (elagolix)
- Oxervate™ (cenegermin) ophthalmic solution
- Oxistat® (oxiconazole)
- Oxycodone-Acetaminophen Products
- Ozurdex® (dexamethasone intravitreal implant)
- Plantar Fasciitis Treatments
- Preferred Multiple Sclerosis Products
- Pyrukynd® (mitapivat)
- Qelbree™ (viloxazine)
- Qelbree™ (viloxazine)
- Qulipta™ (atogepant)
- Qulipta™ (atogepant)
- Qutenza® (capsaicin) 8% patch
- Quviviq™ (daridorexant)
- Reduction Mammaplasty
- Rexulti (brexpiprazole)
- Rheumatoid Arthritis: Biologic Markers and Pharmacologic Assessment
- Rituximab products
- Rocklatan® (netarsudil and latanoprost)
- RoxyBond™ tablet, oral ONLY (not feeding tubes)
- Rybrevant (amivantamab-vmjw)
- Skyrizi® (risankizumab-rzaa)
- Spinal Fusion Surgery
- Spinraza® (nusinersen) injection
- Sublingual Allergen Extract
- Tafinlar® (dabrafenib)
- Tafinlar® (dabrafenib)
- Tecfidera® (dimethyl fumarate)
- Topical Antifungals
- Topical Imidazole Antifungals (Econazole, Oxistat®)
- Tyvaso® (treprostinil)
- Valstar (valrubicin)
- Vancomycin
- Vancomycin capsules
- Vijoice® (alpelisib) tablets
- Vitamin D Testing
- VPRIV® (velaglucerase alfa)
- VPRIV® (velaglucerase alfa)
- Wakix® (pitolisant)
- Xeloda (capecitabine)
- Xenazine® (tetrabenazine)
- Xiaflex® (collagenase clostridium histolyticum)
- Yervoy® (ipilimumab)
- Yosprala® (aspirin and omeprazole)
- Zelboraf® (vemurafenib)
- Zelboraf® (vemurafenib)
- Zeposia® (ozanimod) capsules
- Ztalmy® (ganaxolone) Oral Suspension
Click here to view the Humana Medical Policy Updates Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.